These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 27864176)
1. Insights into the Biosynthesis of Duramycin. Huo L; Ökesli A; Zhao M; van der Donk WA Appl Environ Microbiol; 2017 Feb; 83(3):. PubMed ID: 27864176 [TBL] [Abstract][Full Text] [Related]
2. Nine post-translational modifications during the biosynthesis of cinnamycin. Ökesli A; Cooper LE; Fogle EJ; van der Donk WA J Am Chem Soc; 2011 Aug; 133(34):13753-60. PubMed ID: 21770392 [TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of immunity controls the onset of cinnamycin biosynthesis in Streptomyces cinnamoneus DSM 40646. O'Rourke S; Widdick D; Bibb M J Ind Microbiol Biotechnol; 2017 May; 44(4-5):563-572. PubMed ID: 27858169 [TBL] [Abstract][Full Text] [Related]
4. Substrate-assisted enzymatic formation of lysinoalanine in duramycin. An L; Cogan DP; Navo CD; Jiménez-Osés G; Nair SK; van der Donk WA Nat Chem Biol; 2018 Oct; 14(10):928-933. PubMed ID: 30177849 [TBL] [Abstract][Full Text] [Related]
5. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides. Claesen J; Bibb M Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16297-302. PubMed ID: 20805503 [TBL] [Abstract][Full Text] [Related]
6. Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Widdick DA; Dodd HM; Barraille P; White J; Stein TH; Chater KF; Gasson MJ; Bibb MJ Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4316-21. PubMed ID: 12642677 [TBL] [Abstract][Full Text] [Related]
7. Roseocin, a novel two-component lantibiotic from an actinomycete. Singh M; Chaudhary S; Sareen D Mol Microbiol; 2020 Feb; 113(2):326-337. PubMed ID: 31696567 [TBL] [Abstract][Full Text] [Related]
8. Exploring the potential of radiolabeled duramycin as an infection imaging probe. Kumar A; Mitra JB; Khatoon E; Pramanik A; Sharma RK; Chandak A; Rakshit S; Mukherjee A Drug Dev Res; 2024 Feb; 85(1):e22138. PubMed ID: 38078492 [TBL] [Abstract][Full Text] [Related]
9. Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. Märki F; Hänni E; Fredenhagen A; van Oostrum J Biochem Pharmacol; 1991 Oct; 42(10):2027-35. PubMed ID: 1741778 [TBL] [Abstract][Full Text] [Related]
10. Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases. Zhang X; van der Donk WA Methods Enzymol; 2009; 462():117-34. PubMed ID: 19632472 [TBL] [Abstract][Full Text] [Related]
11. Chapter 21. In vitro studies of lantibiotic biosynthesis. Li B; Cooper LE; van der Donk WA Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997 [TBL] [Abstract][Full Text] [Related]
12. [Semi-in vitro biosynthesis of cryptic lanthipeptide CLA 124 from Streptomyces clavuligerus]. Zhang Z; Zhang L; Zhang J; Ma H; Sun S; Zhong J Wei Sheng Wu Xue Bao; 2015 Nov; 55(11):1402-8. PubMed ID: 26915221 [TBL] [Abstract][Full Text] [Related]
13. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides. Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830 [TBL] [Abstract][Full Text] [Related]
14. Mathermycin, a Lantibiotic from the Marine Actinomycete Marinactinospora thermotolerans SCSIO 00652. Chen E; Chen Q; Chen S; Xu B; Ju J; Wang H Appl Environ Microbiol; 2017 Aug; 83(15):. PubMed ID: 28576760 [TBL] [Abstract][Full Text] [Related]
15. Epidermin and gallidermin: Staphylococcal lantibiotics. Götz F; Perconti S; Popella P; Werner R; Schlag M Int J Med Microbiol; 2014 Jan; 304(1):63-71. PubMed ID: 24119540 [TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate. Velásquez JE; Zhang X; van der Donk WA Chem Biol; 2011 Jul; 18(7):857-67. PubMed ID: 21802007 [TBL] [Abstract][Full Text] [Related]
17. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing. Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031 [TBL] [Abstract][Full Text] [Related]
18. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin. Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031 [TBL] [Abstract][Full Text] [Related]
19. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering. Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974 [TBL] [Abstract][Full Text] [Related]
20. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. Zhao M; Li Z; Bugenhagen S J Nucl Med; 2008 Aug; 49(8):1345-52. PubMed ID: 18632826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]